港股异动 | 福森药业(01652)盘中涨近74% 恩扎卢胺软胶囊获批上市二甲双胍恩格列净片拟中选国家集采

智通财经10-31

智通财经APP获悉，福森药业(01652)盘中涨近74%，截至发稿，涨49.28%，报1.03港元，成交额1037.15万港元。消息面上，福森药业公告，集团的全资附属公司嘉亨(珠海横琴)医药科技有限公司研发的“恩扎卢胺软胶囊”，上市申请已获得中华人民共和国国家药品监督管理局批准，批准用于以下疾病的治疗：有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者；雄激素剥夺治疗(ADT)...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2579481924?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-10-31 10:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579481924","market":"hk","top_or_hot":-1,"title":"港股异动 | 福森药业(01652)盘中涨近74% 恩扎卢胺软胶囊获批上市 二甲双胍恩格列净片拟中选国家集采","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，福森药业(01652)盘中涨近74%，截至发稿，涨49.28%，报1.03港元，成交额1037.15万港元。消息面上，福森药业公告，集团的全资附属公司嘉亨(珠海横琴)医药科技有限公司研发的“恩扎卢胺软胶囊”，上市申请已获得中华人民共和国国家药品监督管理局批准，批准用于以下疾病的治疗：有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者；雄激素剥夺治疗(ADT)...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1363489.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 福森药业(01652)盘中涨近74% 恩扎卢胺软胶囊获批上市 二甲双胍恩格列净片拟中选国家集采</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 福森药业(01652)盘中涨近74% 恩扎卢胺软胶囊获批上市 二甲双胍恩格列净片拟中选国家集采\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-31 10:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1363489.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，福森药业(01652)盘中涨近74%，截至发稿，涨49.28%，报1.03港元，成交额1037.15万港元。消息面上，福森药业公告，集团的全资附属公司嘉亨(珠海横琴)医药科技有限公司研发的“恩扎卢胺软胶囊”，上市申请已获得中华人民共和国国家药品监督管理局批准，批准用于以下疾病的治疗：有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者；雄激素剥夺治疗(ADT)...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1363489.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1363489.html","article_id":"2579481924","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579481924","pubTimestamp":1761877845,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，福森药业盘中涨近74%，截至发稿，涨49.28%，报1.03港元，成交额1037.15万港元。福森药业同时公布，旗下产品二甲双胍恩格列净片，于日前公布的中国第十一批全国药品集中采购招标结果中拟中标。据悉，福森药业今年9月公布，集团研发的“二甲双胍恩格列净片”，上市申请已获得中国国家药品监督管理局批准。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","01652":"福森药业"},"translate_title":"Changes in Hong Kong stocks | Fusen Pharmaceutical (01652) rose nearly 74% intraday, enzalutamide soft capsules were approved for marketing, metformin and empagliflozin tablets are planned to be selected for national centralized procurement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01652":1.5},"content_text":"智通财经APP获悉，福森药业(01652)盘中涨近74%，截至发稿，涨49.28%，报1.03港元，成交额1037.15万港元。消息面上，福森药业公告，集团的全资附属公司嘉亨(珠海横琴)医药科技有限公司研发的“恩扎卢胺软胶囊”，上市申请已获得中华人民共和国国家药品监督管理局批准，批准用于以下疾病的治疗：有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者；雄激素剥夺治疗(ADT)失败后无症状或有轻微症状且未接受化疗的转移性去势抵抗性前列腺癌(CRPC)成年患者。福森药业同时公布，旗下产品二甲双胍恩格列净片(I)(盐酸二甲双胍500mg和恩格列净5mg)，于日前公布的中国第十一批全国药品集中采购招标结果中拟中标。据悉，福森药业今年9月公布，集团研发的“二甲双胍恩格列净片(I)”，上市申请已获得中国国家药品监督管理局批准。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579481924","isCrawlerRequest":true}

港股异动 | 福森药业(01652)盘中涨近74% 恩扎卢胺软胶囊获批上市 二甲双胍恩格列净片拟中选国家集采

精彩评论

港股异动 | 福森药业(01652)盘中涨近74% 恩扎卢胺软胶囊获批上市二甲双胍恩格列净片拟中选国家集采